Amarantus Bioscience Holdings, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/511b0d64-5c6a-4d54-831b-adac1d68803e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-021238 |
| FY 2013 | $416.0k | 2008-01-14 – 2014-03-31 | evidence 0001144204-14-032563 |
| FY 2012 | $416.0k | 2008-01-14 – 2013-03-31 | evidence 0001255294-13-000348 |
| FY 2011 | $416.0k | 2008-01-14 – 2012-03-31 | evidence 0001255294-12-000340 |
| FY 2010 | $192.4k | 2010-01-01 – 2010-12-31 | evidence 0001255294-12-000249 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Amarantus Bioscience Holdings, Inc. — all facts · Net Income · Operating Income